Buy Klow Blend Research Peptide UK | Longevity Formula

KLOW Blend is a four-component research peptide combination formulated for laboratory studies focused on tissue repair, immune modulation, and cellular regeneration. The blend comprises: GHK-Cu (CAS 49557-75-7) — copper tripeptide studied for ECM remodelling and collagen synthesis; TB-500 — actin-sequestering Thymosin β4 fragment (parent CAS 107761-42-2) studied for cellular migration and angiogenesis; BPC-157 (CAS 137525-51-0) — gastric pentadecapeptide studied for tissue regeneration and GI mucosal protection; and KPV — alpha-MSH C-terminal tripeptide studied for MC1R-mediated anti-inflammatory signalling.

The combination targets complementary repair and regeneration pathways: angiogenic (TB-500/BPC-157), matrix remodelling (GHK-Cu), and immunomodulatory (KPV), making KLOW Blend useful in multi-target preclinical research on skin biology, wound healing, and inflammatory tissue response.

Components: GHK-Cu · TB-500 · BPC-157 · KPV · Purity: ≥99% HPLC (each component) · Format: Lyophilised powder blend · Storage: −20 °C

Research Areas: Multi-target tissue repair · ECM remodelling · Wound healing · Anti-inflammatory signalling · Angiogenesis · Cellular migration · Skin biology

Research Literature:
• BPC-157: wound healing and angiogenesis in vivo (PMID 25995620)
• GHK-Cu as anti-aging peptide (PMID 35083444)
• Thymosin beta4 accelerates wound healing (PMID 10469335)

Multi-Buy Savings — Add 2+ products to save 4% automatically. Add 3+ to save 6%. Applied at checkout.

Cartridge Configuration. All cartridge variants are supplied as a pre-mixed, water-based solution, fully enclosed within a sealed, single-use disposable cartridge assembly.

Research Use Only. Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.